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Summary 
Immunological and biochemical characteristics of the Qa-2 routine nonclassical  histocompatibility 
class 1 antigen expressed on tumor cells derived from H-2  k (Qa-2-) mice were studied.  It was 
found  that  the  Qa-2  antigen  on  normal  H-2  b  lymphocytes  reacted  with  Qa-2-specific 
monoclonal antibodies (mAbs) 34-1.2, 59 (both specific  to the oil/a2 region) and 141-15.8 (specific 
to the c~3 domain), and the Qa-2 antigen on H-2  k tumor cells (Qa-2 ~ antigen)  reacted with 
mAbs 59 and 141-15.8, but not with 34-1.2. The normal Qa-2 antigen was susceptible to treatment 
with phosphatidylinositol-specific  phospholipase C, but the Qa-2 k antigen was insensitive to 
it. By Northern hybridization,  polymerase chain reaction (PCR) studies on cDNA, Southern 
hybridization, Western blotting, and nucleotide sequence analysis, the Q5  k gene was identified 
as the gene encoding the Qa-2  k antigen expressed on BW5147 lymphoma cells derived from 
a mouse of AKR strain (H-2  k, Qa-2-).  The nudeotide sequence of PCR-amplified  BW5147 
Q5  k cDNA showed complete agreement with the reported sequence of exons 1-5 of the Q5  k 
gene of C3H/He. It also showed complete deletion of the region corresponding to exons 6 and 
7, and a very short coding region in exon 8, resulting in very short cytoplasmic domain of the 
product compared with regular class 1 antigens. These characteristics were expected from the 
reported Q5  k genomic sequence. These results revealed that the Qa-2  k antigen was distinct from 
the normal Qa-2 antigen expressed on H-2  b lymphocytes although it cross-reacted with some 
Qa-2-specific mAbs. 
M 
urine Qa  and  TL  antigens  are  nonclassical class I 
histocompatibility antigens encoded by genes in the 
Qa/Tla region, which is located telomeric to the H-2 gene 
region of chromosome 17. H-2 genes are expressed on virtu- 
ally all somatic cells, and expression of Qa and TL antigens 
is restricted to selected subpopulations  of bone marrow-de- 
rived cells. H-2D, K, and L antigens have various allotypes 
that are caused by polymorphism of each gene. In contrast, 
it is thought that the Qa and TL antigens are highly conser- 
vative and that there are only positive and negative pheno- 
types. Such phenotypes of antigen encoded by genes in the 
Qa-2,3 region, which exists adjacent to the H-2 region, corre- 
late highly to H-2 allotypes. For example, all H-2  k mice are 
Qa-2,3  negative  and all  H-2  b mice, except  some artificial 
recombinant mice, are Qa-2,3  positive. Recent analyses of 
the Qa-2,3 region revealed that the region of C57BL/10 mice 
(H-2 b) contained 10 class I genes (1). Among them, Q7  b and 
Q9  b,  (Q9  b differs from Q7  b by only one nucleotide)  were 
shown to code for the Qa-2 phenotype (2, 3). Also in BALB/c 
mice (H-2  a, Qa-2 §  which have seven class 1 genes in this 
region,  the  Q7  d  gene,  which  corresponds  to  Q7  b  of 
C57BL/10,  was shown to code for the Qa-2 antigen (4). In 
C3H/He mice (H-2i), the gene region including QT, and 
a large part of Q9, is deleted (5). This deletion is thought 
to cause the Qa-2-negative phenotype of C3H/He lympho- 
cytes. As described elsewhere, however, we demonstrated that 
most H-2  k tumor cells reacted with a mAb specific to Qa-2 
antigen, and that the tumor Qa-2 antigen gave rise to im- 
munological responses in the H-2  k host mice. It was sup- 
posed that the Qa-2 molecules on H-2  k tumors are encoded 
by one of the genes in the Qa-2,3 gene regions of the H-2  k 
mice. To further study the expression of the Qa-2 antigen 
on the tumor cells, it is essential to identify the gene that 
is silent in normal cells and expressed in the tumor cells. In 
this report we characterized the Qa-2 antigen expressed on 
H-2  k tumor cells and identified its gene in BW5147 cells. 
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Mice.  C3H/He, AKIk, B6, and B6.K1 mice were used.  The 
former two have H-2  k and Qa-2-,3- phenotypes. The latter two 
are H-2  b mice that are congenic with respect to Qa antigens, B6 
being Qa-l-2*3 §  and B6.K1  being Qa-l*2-3 -. 
Cells.  BW5147 is an in vitro cell line derived from a T  cell 
lymphoma of the AKR mouse. MM2 and FM3A are ascites cell 
lines of vitally induced mammary carcinomas of C3H/He. MH134 
is an ascites cell line of a chemically induced hepatoma of C3H/He. 
The in vivo cell lines were maintained by serial passages in the peri- 
toneal cavities of C3H/He. It has been shown that these cell lines 
reacted with a Qa-2-specific mAb 141-15.8. LQ  rb/xb and L  Kb cells, 
which were established  by transfection of Q7b/K  b hybrid gene 
DNA, and H-2K  b genomic DNA, respectively, will be reported 
dsewhere.  LQ  7b/xb cells express  c~1 and cz2 domains of the Q7  b 
gene product and cz3, transmembrane, and cytoplasmic domains 
of the H-2K  b. L  kb ceils express H-2K  b antigen. Both ceils, as well 
as nontransfected L cells, express H-2  k antigens. 
Antibodies.  mAb 141-15.8, which has specificity to the c~1 or 
c~2 domain of the Qa-2 antigen with some cross-reactivity to H-2 
antigens (K  a, D a, L  a, K b, r, s, p, and q) (7, 8), was obtained from 
the American  Type Culture Collection,  Rockviile,  MD.  mAb 
34.1.2,  which recognizes the or3 domain of the Qa-2 antigen and 
did not have cross-reactivity to classical class 1 antigens (8), was 
from Australian  Monoclonal Development, Arlurmon, NSW. A 
hybridoma clone producing Qa-2-specific mAb 59, was newly es- 
tablished by Y. Matsudaira and T. Takahashi by fusing NS-1 cells 
with lymphocytes from B6.K1 immunized with B6 lymphocytes. 
Thy-l.l-specific mAb was purchased from Mdji Institute of Health 
Science, Tokyo, Japan. Thy-l.2-specific mAb was from Cedar Lane 
Laboratories,  Westbury, NY. A mouse mAb of the IgG2b class 
specific to a bacterial component (NusA protein) was kindly provided 
by Dr. Y. Nakamura of this hboratory and used as a mAb not related 
to tumor cell surface antigens. F(ab')2 of goat antibody specific to 
mouse Ig and its FITC derivative were obtained from Tago, Inc., 
Burlingame, CA. Fab' fragment of the antibody was obtained by 
reducing the F(ab')2 with 2-ME and fractionating by Sephacryl 
S-200 column chromatography. 
Treatment of Cells with Phosphatidylinositol-specific  Phospholipase C 
(PI-PLC). I  PI-PLC derived from Bacillus thurigiensis (9) was pur- 
chased  from Sapporo Beer Co.  (Tokyo, Japan).  CeUs (2  x  10  6) 
were incubated at 37~  for 60 min in 30/zl of DMEM (pH 7.5), 
containing 0.1  mU of PI-PLC and 1 rag/m1 of OVA.  After the 
incubation, the cells were washed twice with DMEM and used 
for detection of cell surface antigens. 
Immunofluorescence Analysis.  Detection of cell surface Qa-2 and 
Thy-1 antigens was carried out by flow cytometry (7). Briefly, the 
cells were reacted with Qa-2-specific mAb and then with the FITC- 
labeled F(ab')2 fraction of goat antibody specific to mouse Ig. In 
the cases oflymphocytes, T cells were enriched by passing through 
a nylon wool column, and cell surface Ig of contaminating B ceils 
were blocked by treating with Fab' fragment of the antibody. The 
FITC-labded cells were fixed with 1% paraformaldehyde and ana- 
lyzed using the FACS III|  (Becton Dickinson & Co., Mountain 
View,  CA). 
Preparation of eDNA.  Total cellular RNA was extracted from 
tumor ceils and thymocytes by the guanidine isothiocyanate method 
(10),  and enriched for mRNA by isolating poly(A) + RNA on 
oligo(dT)-cellulose (Boehringer Mannheim Diagnostics GmbH, 
1 Abbreviations used in this paper: GPI, glycophosphatidylinositol;  PI-PLC, 
phosphatidylinositol-spedfic  phospholipase  C; TTBS, Tween  20-containing 
Tris-buffered saline. 
Mannheim, Germany) (11). Synthesis of cDNA from the mRNA 
was carried out using a cDNA synthesis kit (cDNA Plus; Amer- 
sham Corp., Arlington Heights, IL) with oligo-dT as a primer. 
Oligonucleoa'dePrimersandPwbes.  Based on the reported nucleo- 
tide sequences of genes in the Qa-2,3 region of C3H/He (5),  11 
20  met oligonucleotides were prepared on a DNA  synthesizer 
(model 391; Applied Biosystems Inc., Wilmington, NC) and used 
as primers for PCR, and also for DNA sequencing. Their sequences 
and specificities are shown in Table I and Fig. 1. Oligonucleotides 
1-6 were complementary to specific antisense  sequences found in 
the first exons of each of the H-2D  k, Q1 k, Q2  k, Q4  k, Q5  k, and 
Q10  k genes, respectively. Nos. 10 and 11 were complementary to 
a QS~-specific sense sequence in exons 8 and 7, respectively. Nos. 
7-9 were complementary to sequences common to all class I genes. 
Oligonucleotides complementary to Nos. 1-6 (Nos. 12-17, respec- 
tively) were also synthesized and used as probes in Northern hy- 
bridization experiments. 
PCR.  PCR was carried out in 100 #1 reaction mixture con- 
taining 50 ng of DNA, 50 pmol each of primers complementary 
to sense and antisense  sequences, 20 mM Tris-chloride  (pH 8.3), 
1.5  mM  MgCI~,  25  mM  KC1, 0.05%  Tween  20,  0.1  mg/ml 
gelatin, 50/zM each of dNTP, and 2 U of Taq DNA polymerase 
(Perkin-Elmer/Cetus Corp., Norwalk, CT). The reaction mixture 
was overlayed with 100 #1 of mineral oil to prevent evaporation. 
The thermal cycler (Atto, Tokyo, Japan) was run for 40 cycles (each 
for 1 min at 94~  1.8 rain at 55~  and 2 min at 72~ 
Cloning and Sequencing of  PCR-amplified DNA.  DNA amplified 
by PCR was  sequenced  either directly or after cloning into the 
SmaI site of pUC119. For the cloning, competent Escherichia coli 
MVl184 cells were transformed with the plasmid DNA and grown 
on a plate containing Xgal, IPTG, and ampicillin. White colonies 
were picked and grown in 2 x  YT broth. The cells were then in- 
fected with M13K07 helper phage. The resulting  single-strand 
DNA, as well as the PCK-amplified DNA, was sequenced by the 
dideoxy method (12) using a DNA sequencing kit (Sequenase ver- 
sion 2.0; U.S. Biochemical Corp., Cleveland,  OH), and synthetic 
oligonucleotides were used as PCR primers or M13 universal primer. 
Preparation of Genomic DNA and SouthernHyb~dization.  Spleno- 
cytes from B6, C3H/He, AKB,, and BW5147 cells were incubated 
at 60~  overnight in 0.03% SDS solution containing 0.1 mg/ml 
proteinase K and then extracted with phenol. The resulting aqueous 
phase was dialyzed overnight against 10 mM Tris-chloride (pH 7.5) 
containing 1 mM EDTA and used as the DNA solution.  10/xg 
each of genomic DNA was digested with HindlII or with BamHI, 
subjected to electrophoresis through 0.8% agarose gel, and trans- 
ferred onto a nylon filter (Hybridon-N+ ; Amersham Corp.,). The 
filter was dried at 37~  and incubated for 1 h at 60~  in 6 ml 
of hybridization buffer (6x  SSC, 5 x  Denhardt's solution, 0.5% 
SDS, 50% formamide, 20 mM sodium phosphate buffer, pH 6.5) 
containing i  mg of salmon sperm DNA. The DNA probe that 
had been labeled with 32p by the random primer method was then 
added to the incubation. Hybridization was carried out at 42~ 
overnight. The filter after the hybridization was washed twice at 
room temperature for 15 rain in 2x  SSC containing 0.1% SDS 
and twice at 37~  for 30 min in 0.2x  SSC containing 0.1% SDS. 
The filter was then rinsed with 0.1 x  SSC and exposed to x-ray 
film using an intensifier screen. 
Northern Hybridization.  Poly(A) + RNA  was  prepared as de- 
scribed above from AKR thymocytes and BW5147 cells, denatured 
with glyoxal, subjected to electrophoresis through a 1.2% agarose 
gel containing 20 mM phosphate buffer (pH 7.4), and transferred 
onto a nylon filter. The filter was dried at 37~  and incubated for 
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#g salmon sperm DNA. Oligonucleotide  probes, 5'-terminus of 
which had been labeled with 32p, were then added to the incuba- 
tion. After incubating at 42~  overnight,  the filter was washed 
twice with 2x  SSC for 15 min at room temperature, and twice 
with 2x SSC containing 0.1% SDS for 30 min at 50"C. The filter 
was then rinsed with 0.2x  SSC and exposed to x-ray film using 
an intensifier screen. 
Synthesis of Q5  k Protein and  Western Blotting.  DNA  corre- 
sponding to exons 1-4 of the Q5 k gene that had been amplified 
from BW5147 cDNA was cloned into pUC119 and sequenced as 
described above. A colony was selected that had the insertion in 
the right direction and in frame downstream of the lacZ promoter. 
This colony was grown in L broth containing ampicillin until the 
optical density at 600 nm reached 0.3. IFTG was added to the cul- 
ture to 50 #M and culturing continued until the optical density 
became 0.75. The cells were harvested, precipitated with 10% TFA, 
washed with acetone, and dissolved  by heating for 30 min at 100~ 
in 25 mM Tris-hydrochloride (pH 6.8) containing  2% SDS, 5% 
glycerol, 0.0125% bromophenol blue, and 2.5% 2-ME. The dis- 
solved material was subjected to electrophoresis through a 12% 
polyacrylamide  gel containing 0.1% SDS and transferred onto poly- 
vinyl difluoride  membrane  (Immobilon;  Millipore  Continental 
Water Systems, Bedford, MA) by electroblotting in a solution com- 
posed of 25 mM "Iris base, 192 mM glycine, 20% methanol, and 
0.02% SDS. The membrane was then rinsed with 0.15 M sodium 
chloride containing 0.2% Tween 20 and buffered with 10 mM Tris 
hydrochloride (pH 7.6) (TTBS), incubated for 2 h at 37~  in TTBS 
containing 10% goat and 10% horse serum. The membrane was 
rinsed with water and incubated overnight at room temperature 
in 200 x  diluted mouse ascites containing mAb 59 in 5 ml of the 
same medium. After incubation,  the filter was rinsed three times 
with TTBS and reacted for 1 h at 37~  with peroxidase-labeled 
anti-mouse IgG (Amersham Corp.) in saline buffered with 10 mM 
Tris-borate (pH 7.6). The membrane was again washed three times 
with TTBS and treated for coloration in 50 ml of  TTBS containing 
40 mg of 3,3'-diaminobenzidine tetrahydrochloride (Wako Chem- 
icals, Osaka, Japan) and 15 #1 of 30% hydrogen peroxide. 
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Figure 1.  Synthetic  deoxyoligonucleotide  primers used in this study. 
(Arrows) Positions and 5' to 3' orientations of the primers. 
Results 
Characteristics of the Qa-2 Antigen Expressed on Tumor Cells 
Derived from 1-1-2  k Mice.  As reported elsewhere, we demon- 
strated that most tumor cell lines (seven of nine cell lines 
tested) derived from H-2  k (Qa-2-) mice express the Qa-2 
antigen  detected  by  the  membrane  immunofluorescence 
method using anti-Qa-2 antiserum or Qa-2-specific mAb 
141-15.8. It was found, however, that the Qa-2 antigen was 
not  detected on these cells  in  general when  another Qa- 
2-specilic mAb 34-1.2 was used. Qa-2 specificity of  the newly 
obtained mAb 59 was examined and compared with those 
ofmAbs 141-15.8 and 34-1.2 (Table 2). It is evident that mAb 
59 recognizes the od or o~2 domain of the Qa-2 molecule, 
which is the product of the Q7  b gene, and does not cross- 
react with at least the H-2  k and H-2  b antigens. Unlike mAb 
34-1.2,  mAb  59 reacted not only with H-2  b lymphocytes 
but also  with various H-2  k tumor ceils  such as MM2 and 
BW5147. Distribution of mAb 59-reactive antigen among 
various tumor cells derived from H-2  k mice was essentially 
identical to that of the antigen reactive to mAb 141-15.8 (data 
not shown). Such reactivity to Qa-2-specific mAbs indicates 
that these tumor cells express a Qa-2 antigen that is closely 
related but not identical to the Qa-2  antigen detected on 
normal lymphocytes of H-2  b mice, and that the od or or2 
domain of the molecule is responsible for at least a part of 
the difference. Table 2 also shows that the Qa-2 antigen was 
Table  1.  Synthetic Deoxyoligonucleotides Used as Primers and Probes 
No.  Sequence (5'-3')  Specificity 
1  TGGCCCCGGCTCAGACCCGC  H-2D  k 
2  TGACCCTGACCAAAACCGGA  QI  k 
3  CCCGGACCCAGAACCGAGCC  Q2  k 
4  AGTCGCCCAGACCCTGATCG  Q4  k 
5  CTCTGACCCAGACCCGCGCT  Q5  k 
6  CCCCGACCCAGACCCAGGCA  QI~ 
7  GCTGGGCCCTGGGCTTCTAC  panclassl 
8  AGGGTGAGGGGCTCAGGCAG  pan dassl 
9  CTGGCAGTTGAATGGGGAGG  panclassl 
10  ATCGTCTGTCACTCAGTCCA  Q5 k 
11  GCTCTAGGAGCTGTCCCTGC  Q~ 
12-17" 
* Complementary to nos. 1-6, respectively. 
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Using Anti-Qa-2 Polyclonal and Monoclonal Antibodies 
Qa-2-specific  mAb 
Nonrelated 
Cell  34-1.2  59  141-15.8  mAb 
B6 lymphocyte  156.1  59.0  22.3 
B6.K1 lymphocyte  30.7  25.0  30.9 
C3H/He thymocyte  16.7  17.4  16.6  16.8 
AKR thymocyte  18.1  19.2  19.5  18.0 
MM2  58.9  101.3  102.8  64.8 
BW5147  46.4  80.4  102.3  45.2 
L  QTb/Kb  192.0  180.2  42.1  48.4 
L  Kb  81.2  68.2  71.5 
Data are mean fluorescence intensity. 
not detected on thymocytes and splenocytes  of H-2  k mice 
(C3H/He and AKR) when either one of these mAbs was 
used. 
It has been reported that the Qa-2 antigen expressed on 
lymphocytes obtained  from  H-2  b  mice  is  susceptible  to 
digestion with PI-PLC (13), showing that the molecule is 
anchored to the cell membrane via a glycophosphatidylinositol 
(GPI) moiety. It is known that the GPI structure is linked 
to an aspartic  acid of the cell surface protein molecule (14). 
With regard to the Qa-2 molecule, the GPI anchor has been 
supposed to be linked to an aspartic acid residue at position 
295 coded by a CAC in exon 5 of Q7  b gene (15).  In H-2 
antigen molecules, which are resistant to treatment with PI- 
PLC, this aspartic  acid residue is replaced  by valine.  DNA 
sequences of genes of the Qa-2,3 region reported so far show 
that all putative Q gene products other than Q7 and Q9 (16) 
have valine at this position. From these observations,  it was 
supposed that the Qa-2  antigen expressed  on H-2  k tumor 
cell surfaces might be resistant to PI-PLC treatment. As shown 
Table 4.  Susceptibility of Thy-1 Antigens to PI-PLC Treatment 
PI-PLC treatment 
Nonrelated 
Anti-Thy-l.1  Anti-Thy-l.2  mAb 
Cell  -  +  -  + 
AKR thymocyte  193.0  98.0  34.5 
B6 thymocyte  176.0  79.7  40.1 
BW5147  176.0  95.1 
Data are mean fluorescence  intensity. 
in Table 3, Qa-2 molecules detected by mAb 141-15.8 on var- 
ious tumor cells derived from H-2  ~ mice were resistant to 
PI-PLC treatment. In a control experiment, susceptibility of 
the Thy-1 antigen on BW5147 cells was tested. The Thy-1 
antigen is also known to be one of the cell surface molecules 
having a GPI anchor (17). As shown in Table 4, the Thy-1 
antigen expressed  on BW5147 cells was susceptible  to PI- 
PLC treatment. This result showed that the lack of a GPI 
anchor on the Qa-2 antigen of BW5147 cells was not due 
to a defect in the cellular mechanism to synthesize GPI an- 
chors, but due to biochemical differences of the Qa-2 mole- 
cules themselves. 
From these observations,  it is evident that the Qa-2 an- 
tigen  expressed  on  tumor  cells  derived  from  H-2  k mice 
(Qa-2  k antigen) is distinct immunologically and biochemi- 
cally from that expressed on H-2  b normal lymphocytes. The 
Qa-2  k  antigen  can  be  tentatively  defined  as  a  PI-PLC- 
resistant molecule expressed  on tumor cells derived from 
H-2  k mice, which is reactive to mAbs 59 and 141-15.8, but 
not to mAb 34-1.2. 
Identification of the Gene Encoding the Qa-2 k Phenotype of 
BW5147  Cells.  Among  the  Qa-2k-positive  tumor  cells, 
BW5147 cells grown in vitro were selected for further anal- 
Table 3.  Susceptibility of Qa-2 Antigens to PI-PLC Treatment 
Cell 
PI-PLC Treatment 
mAb 141-15.8  Nonrelated mAb 
+  --  + 
B6 lymphocyte  152.0  59.7  30.6  29.4 
BW5147  85.1  96.4  35.8  36.2 
MM2  88.2  98.0  73.2  74.6 
FM3A  108.0  109.3  71.1  72.3 
MH134  101.2  102.9  67.9  72.5 
Data are mean fluorescence intensity. 
650  Qa-2  k Antigen on Tumor Cells Derived from H-2  k Mice Figure 2.  Southern  blot analysis  of  B6, C3H/He, 
AKK, and BW5147 genomic  DNA digested with 
HindlII or BamHI. DNA amplified  by PCR from 
cDNA of BW5147 cells using primers nos. 5 and 8 
was labeled with 32p and used as the probe. 
yses because expression of Qa-2  k was fairly strong, and also 
because the cells could be obtained without contamination 
of cells from the host  animals.  Fig.  2  shows the results of 
Southern hybridization analyses in which HindIII or BamHI 
fragments of genomic DNAs were hybridized with a 32p. 
labeled DNA probe of about 800 bp that could detect the 
DNA region containing exons 2-4 of all class 1 genes. The 
patterns  of  autoradiograms  obtained  using  DNAs  from 
C3H/He,  AKR,  and BW5147  cells were essentially iden- 
tical and they were distinct from that obtained using B6 DNA. 
From these results, we assumed that the arrangement of class 
1 genes was conserved among genomes of these H-2  k mice 
(C3H/He and AKR) and that the lymphoma cell line was 
derived from AKR. It was reported that the Qa-2,3 region 
of the C3H/He  genome contained Q1 k,  Q2  k,  Q4  k,  Q5 k, 
and Q10  k genes (5,  18).  The Q3  k gene was a pseudogene, 
and genes corresponding to Q6,  Q7,  Q8,  and a large part 
of Q9 were deleted. The Q5  k gene seemed to be a hybrid 
gene composed of a large 5' part of the Q5 gene and a short 
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3' part of the Q9 gene. We tried to identify the gene that 
was silent in AKK and transcribed in BW5147 by Northern 
hybridization and also by amplification of cDNA by PCR 
using primers and probes specific for each of the Q1 k, Q2  k, 
Q4  k, Q5  k, and Q10  k genes (Table  1 and Fig.  1).  A primer 
and probe specific to H-2D  k gene was also used as a posi- 
tive control. 
Fig.  3  shows  the  results  of  Northern  blot  analysis. 
H-2Dk-specific probe (no. 12) showed a specific hybridizing 
band at 1.5 kb with both AKK thymocy~ RNA and BW5147 
RNA.  In contrast,  QSk-specific  probe (no.  16) hybridized 
to approximately 1.2-,  1.5-,  and 4.0-kb species in BW5147 
RNA,  whereas no hybridization was detected with regard 
to AKR RNA.  Also,  hybridization either to AKK RNA 
or BW5147 RNA was not detected when probe nos. 13, 14, 
15, and 17 were used (data not shown). These results indi- 
cated that Q5  k gene, the transcription of which was not de- 
tected  in  H-2  k  thymocytes,  was  specifically  transcribed 
among Q  genes in BW5147  cells.  In agreement with  the Figure 3.  Northern  blot analysis  of poly(A)  + RNA of BW5147 cells 
and AKK thymocytes.  3/~g of poly(A)  § RNA was used in each slot. 
H-2Dk-specific probe (no. 11) and QSLspecific  probe (no. 15) were 32p. 
labeled and used in I and 2. respectively. 
present observation, transcripts of 4.0,  1.5, and 1.2 kb have 
been reported for both Q7 and Q9 genes (2,  19,  20,  21). 
They were supposed to represent unprocessed transcripts, nor- 
mally spliced  message,  and a truncated form, respectively. 
The transcription of Q5  k gene in BW5147 cells was sup- 
ported  by the results of PCR.  Using primers  specific  to 
H-2D  k, Q1  k, Q2  k, Q4  k, Q5  k, and Q10  k (nos.  1-6,  respec- 
tively) and a primer (no.  8)  that was complementary to a 
dass I common sense sequence  in the 3'-terminal region of 
exon  4,  the  PCR  was  carried  out.  As  shown in  Fig.  4, 
amplification of BW5147 cDNA was successful only when 
primer nos.  I and 5, which were complementary to H-2D  k 
and Q5  k exon 1 antisense sequences, respectively,  were used 
together with primer no. 8. Amplification was not detected 
when primer nos. 2-6 were used together with primer no. 
8, even  when the annealing temperature was lowered to 45~ 
The DNA amplified using primer nos. 5 and 8 was sequenced 
directly, and also after cloning into pUC119 using primer 
nos.  5,  7,  8,  and universal  primer M13.  The sequence  was 
found to be identical to the reported nucleotide sequence of 
exons  1-4 of the Q5  k gene of C3H/He.  Amplification of 
genes other  than Q5  k was  not detected during direct  se- 
quencing. Amplification of the H-2D  k sequence from AKR 
cDNA was also detected using primer nos. 1 and 8, showing 
that synthesis of AKR cDNA was successful. However, none 
of the Q-spedfic sequences could prime amplification of the 
AKR cDNA. Amplification ofBW5147 cDNA was observed 
also when primer no. 9, which was complementary to a class 
I common antisense sequence in exon 4, and primer no.  10, 
which was complementary to a Q5k-specific sense sequence 
in exon 8, were used. The nucleotide sequence of the DNA 
amplified using these primers was determined directly using 
primer nos. 9 and 10. A part of the resulting sequence and 
the deduced amino acid sequence are shown in Fig. 5. Con- 
taminating sequences were not detected in this case also. It 
showed substantial differences from the reported sequences 
of regular class 1 cDNA. Nine additional nucleotides were 
found between exons 4 and 5.  This addition was expected 
from the reported genomic DNA sequence of the Q5  k gene 
of C3H/He because the 5'-terminal sequence of intron 4 of 
Q5  k was GC, whereas those of other class 1 genes in general 
were splice donor GT, and the GT 9 bases downstream of 
the GC could be used as a splice donor. In the Q7  a gene of 
BALB/c mice, the latter GT was reported to be a splice donor 
and addition of nine bases, which coded for additional GRW, 
was also observed (5). The sequence of exon 5, which coded 
for the transmembrane domain, was identical to the reported 
sequence  of exon 5  of C3H/He Q5  k,  but exons 6  and 7 
were deleted and only two bases in exon 8 were included 
in the coding region. This deletion was also expected from 
the genomic sequence because the 5'- and 3'-terminal sequences 
of intron 6 were CA and TG, respectively, whereas those of 
most other class I genes were splice donor GT and splice ac- 
ceptor AG. These changes may result in a truncated mRNA 
ending at exon 6, which may be labile, and a mRNA deleting 
exons 6 and 7. A GTC coding for valine in exon 5 was con- 
served,  which corresponds to the CAC coding for aspartic 
Figure 4.  Amplification  of eDNA by PCR. A, 
AKR cDNA; B, BW5147 cDNA. Probes specific  for 
Q10  k (I), Q5  k (2), Q4  k (3), Q2  k (4), ql  k (5), and 
H-2D  k (6) were used. A 10 #1 quantity of the re- 
suiting  reaction  mixture  was subjected  to electropho- 
resis through  a 1% agarose  gel and DNAs  were  visual- 
ized by ethidium  bromide. The positions of marker 
deoxypolynucleotides  with known sizes in kilobase 
pairs are given on the right. 
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G  AGA  TGG  GGC  AAG  GAG  GAG  CCT  CCT  TCA  TCC  ACC  AAG  ACT  AAC  ACA  GTA ATC  ATT  GCT  GTT 
R  W  G  K  E  E  P  P  S  S  T  K  T  N  T  V  I  I  A  V 
CCG  GTT  GTC  CTT  GGA  GCT  GTG  GTC  ATC  CTT  GGA  GCT  GTG  GTG  GCT  TTT  GTG  ATG  AAG  AGG  AGG 
P  V  V  L  G  A  V  V  I  L  G  A  V  V  A  F  V  M  K  R  R 
exon  5 ]  exon  8 
AGAAAC  ACAGGG  TGA AGACAG  CTG  CC 
R  N  T  G  end 
Figure  5.  Deoxynucleotide  se- 
quence of the region  of Q5  k  cDNA 
encoding  the COOH-terminal  part 
of the Q5  k protein and its deduced 
amino acid sequence. 
acid at position 295 of Q7  b, in the transmembrane domain. 
The lack of aspartic  acid residue at this position could be 
responsible for the resistance of the molecule to PI-PLC treat- 
ment  (15). When  PCR  was  carried  out  with  BW5147 
genomic DNA using primer no.  11, which was specific to 
exon 7 sequence  and primer no. 9,  amplification of DNA 
with length expected from the genomic sequence (1,020 bp) 
was observed,  whereas amplification of the cDNA was not 
detected when primer no. 11 was used together with primer 
nos.  7 or 9.  These results indicated that deletion of exons 
6  and 7 did not take place  in the genomic DNA. 
To determine whether the Q5  k gene of BW5147 codes for 
the immunologically defined Qa-2 antigen, Western blot- 
ting analysis was carried out on the peptide encoded by the 
DNA sequence amplified by PCR using primers nos.  5 and 
9.  The amplified DNA  was ligated into the SmaI site  of 
pUC119 and a clone was selected  by DNA sequencing in which 
Q5  k exons  1-4 were fused in frame in the right direction 
Figure 6.  Reactivity  to Qa-2-specific  mAb of the fusion  protein com- 
posed of the cd to ~x3 domains of the Q5  k protein and lacZ. (,'1) Lysate 
of E.  coli transformed  with the plasmid containing  exons 1-4 of Q5  k 
cDNA and cultured  in the presence  of  IPTG  was electrophoresed  and stained 
with coomassie  blue; (B) E. coli transformed  with pUC119 was treated 
in the same  way;  and (C) Western  blotting  of  A using  Qa-2-specific  mAb 
59.  Positions of standard proteins with known molecular masses in 
kilodahons  are shown.  (Arrows) The position  of the protein  induced  with 
IFIG. 
downstream of the lacZ initiation codon. The plasmid was 
introduced into competent E.  coli MVl184 cells and the ex- 
pression of the lacZ-Q5 k fusion protein was induced by cul- 
turing the cells in the presence  of IPTG.  As shown in Fig. 
6, the resulting cells showed the induced synthesis of a pep- 
tide with molecular mass of about 35  kD, which was the 
value expected from the fusion protein. This 35-kD protein 
reacted with anti-Qa-2 mAb 59.  The protein was not de- 
tected under identical conditions when anti-Qa-2 mAb 34- 
1.2 was used. 
From these results,  we concluded that the Qa-2  k antigen 
on the surface of BW5147 cells, which was detected by mAb 
59 but not by mAb 34-1.2,  and which was resistant to treat- 
ment with PI-PLC, was the product of the Q5  k gene which 
was inactive in normal tissues and cells of adult AKR mice. 
Discussion 
The results presented in this communication clearly show 
that the antigen detected by mAbs with Qa-2 specificity on 
various tumor cells derived from Qa-2  k mice was distinct 
from that detected on normal H-2  b lymphocytes, the former 
being Q5 gene product and the latter Q7 or Q9 gene product. 
Therefore, despite the cross-reactivity,  the tumor Qa-2 an- 
tigen is not an illegitimately  expressed normal allogeneic an- 
tigen. Such cross-reactivity to normal antigens may be a fea- 
ture of tumor antigens coded for by genes  that belong to 
the  same  highly homologous multigene family with  the 
normal antigen genes. Biochemical characteristics of the tumor 
Qa-2  k antigen described here could be expected from the 
reported genomic DNA sequence  of the Q5  k gene. Resis- 
tance of the tumor Qa-2 antigen to PI-PLC treatment may 
be attributed to a change of one nucleotide in the exon 5 
which will result in a D  to V change. Deletion of exons 6 
and 7 in the cDNA seems to take place during splicing  of 
mRNA, because the result of PCR indicated that BW5147 
genomic DNA contained these exons, and the deletion may 
be caused by changes in the splice site in the intron 6.  A 
very short cytoplasmic domain of the tumor Qa-2 antigen 
is the result of a stop codon in the exon 8 close to 5'-terminus 
of the exon 5, whereas an even shorter cytoplasmic domain 
of the Q7  b gene product caused by a stop codon exists  in 
the exon 5.  Elongation of the exon 4 by nine nucleotides 
compared with Q78 and most other class 1 genes could also 
be attributed to the change in the splice donor site in the 
intron 4. Therefore,  the Q5  k cDNA sequence matched com- 
pletely to that expected  from the reported genomic DNA 
sequence. 
653  Seo et al. In agreement with the results of Northern blot analyses 
in which Q5  k transcripts were not detected in H-2  k thymo- 
cytes, antigens reactive to Qa-2-specific mAbs were not de- 
tected on H-2  k thymocytes, also, Qa-2-specific antibody was 
detected in C3H/He mice immunized with Qa-2-positive 
syngeneic tumor cells  and in B6 mice immunized with  a 
Q5k-specific  synthetic peptide (unpublished results), These 
findings indicate that the mice are not tolerant to the Q5 
gene product and therefore the Q5 gene may not be expressed 
in the normal adult H-2  k and H-2  b mice. Mechanism of Q5 
gene expression in tumor cells will be a point of interest in 
future studies. 
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